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Abstract
Tinnitus, the phantom perception of sound, is a frequent disorder that causes significant morbidity and treatment
is elusive. A large variety of different treatment options have been proposed and from most of them some
patients benefit. However, a particular treatment that helps one patient may fail for others. This suggests that there
are different forms of tinnitus which differ in their pathophysiology and their response to specific treatments.
Therefore, it is a major challenge for tinnitus treatment to identify the most promising therapy for a specific
patient.
However, most published clinical treatment studies have enrolled only relatively small patient samples, making it
difficult to identify predictors of treatment response for specific approaches. Furthermore, inter-study comparability
is limited because of varying methods of tinnitus assessment and different outcome parameters. Performing clinical
trials according to standardized methodology and pooling the data in a database should facilitate both clinical
subtypisation of different forms of tinnitus, and identification of promising treatments for different types of tinnitus.
This would be an important step towards the goal of individualized treatment of tinnitus.
For these reasons, an international database of tinnitus patients, who undergo specific treatments, and are assessed
during the course of this treatment with standardized instruments (e.g., psychoacoustic measures, questionnaires)
has been established. The primary objectives of this database are (1) collecting a standardized set of data on
patient characteristics, treatments, and outcomes from tinnitus patients consulting specialized tinnitus clinics all
over the world (at present 13 centers in 8 countries), (2) delineating different subtypes of tinnitus based on data
that has been systematically collected and (3) identifying predictors for individual treatment response based on the
clinical profile. Starting in 2008, the database currently contains data from more than 400 patients. It is expected
that more centers will join the project and that the patient numbers will rapidly grow, so that this international
database will further facilitate future research and contribute to the development of evidence based on individua-
lized treatment.
Background
Chronic tinnitus is a frequent disorder characterized by
high morbidity and a significant reduction in the quality
of a patient’s life [1,2]. Currently, manifold treatment
strategies are in use [3,4]. Some of these approaches
have been investigated in controlled trials [5]. In many
of the controlled treatment trials, average improvement
for the whole sample was negligible, frequently failing to
reach statistical significance. However in many of these
studies there were subgroups of patients for whom spe-
cific treatment strategies were effective. This applies to
clinical trials investigating a large variety of different
treatment interventions, including brain stimulation
techniques [6-11], pharmacotherapy [3], psychotherapy
[12] or auditory stimulation [13,14]. So far, the best
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tinnitus patients is cognitive behavioural therapy [12].
Nevertheless, the results of most of these studies are
characterized by a high interindividual variability of
treatment response. On the one hand, factors not
directly related to tinnitus (e.g., psychosocial stress,
expectation and anticipation of treatment success, etc.)
may contribute to the variability of treatment results.
Indicators for such influences are e.g. the considerable
variability of tinnitus severity over time irrespective of
treatment interventions or the high variability of
response to placebo treatments. On the other hand, the
high variability in treatment results may reflect the
pathophysiologic heterogeneity of the symptom tinnitus.
Tinnitus can be the consequence of many different etio-
logical conditions; it further varies in its perceptual
characteristics (e.g., pulsatile vs. non-pulsatile, intermit-
tent vs. permanent, uni- vs. bilateral tinnitus, pure tone
vs. broadband noise, pitch, loudness, etc.) and in its
comorbidities (hearing loss, hyperacusis, vertigo, audi-
tory processing disorders, affective disorders etc.). It has
to be assumed that these different forms of tinnitus dif-
fer in their pathophysiology and also in their response
to specific treatments. Therefore, a “one fits all”-
approach is not feasible in tinnitus therapy. Further-
more, clinical trials with inhomogeneous patient popula-
tions may reveal false negative results, if positive results
in a small subgroup are diluted by negative results in
the rest of the sample [15]. An example is the treatment
with the anticonvulsant carbamazepine. Whereas several
trials in unselected samples were negative [16,17], a spe-
c i f i cf o r mo ft i n n i t u st h a ti sc a u s e db yv a s c u l a rc o m -
pression of the auditory nerve and characterized by a
“type writer”-like sound, responds to carbamazepine
[18,19]. This example indicates that higher treatment
success can be achieved with specific treatment regimes
for specific subgroups. For such an individualized
approach, determination of predictors of treatment
response is needed but still widely lacking so far.
Since tinnitus is a frequent and chronic disease and
affected patients undergo in many cases different treat-
ment approaches, the socio-economic costs of the dis-
ease are substantial. In order to reduce these costs and
to alleviate the burden of the disease, a better predictor-
based stratification of patients to treatment approaches,
which hold a good chance of positive response in the
individual case, is urgently needed. In order to reduce
the heterogeneity of tinnitus, different forms of tinnitus
should be grouped in subtypes based on e.g. etiologic
factors, clinical appearance or co-morbid medical condi-
tions. This may increase the chances of detecting effec-
tive treatments in distinct tinnitus forms. However,
frequently at the time of the design of a clinical trial, it
is not yet known which subgroup of tinnitus patients
may benefit best from treatment. Moreover, a prerequi-
site for such an approach is a large, well characterised
tinnitus sample.
The first attempt at systematically collecting data
from tinnitus patients is the web-based Oregon Tinnitus
Data Archive [20]http://www.tinnitusarchive.org/. This
free, accessible database contains statistical data summa-
ries of current status and past history of tinnitus, results
of specific tinnitus tests, audiologic status and demo-
graphic and general information in a sample of 1630
tinnitus patients who attended the tinnitus clinic of the
Oregon Hearing Research Center between 1981 and
1994. This database allows a description of basic tinni-
tus characteristics in a large patient sample. This data-
b a s ew a si n t e n d e dt oc o n t r i b u t et o( 1 )b e t t e r
classification of tinnitus, (2) planning etiologic studies,
(3) epidemiologic research, (4) treatment evaluation and
(5) studies of tinnitus mechanisms. This pioneering
work has contributed largely to a better understanding
of tinnitus [21], but it has several important limitations.
First, the Oregon Tinnitus Data Archive only contains
cross-sectional data. Thus, it cannot provide informa-
tion about the interaction between specific tinnitus
characteristics and outcome of specific treatments. The
lack of longitudinal data makes it impossible to use the
database in the search for predictors of treatment out-
come for specific treatment interventions. A second lim-
itation of the database is the highly selected patient
sample. Patients were only recruited in the Oregon
Hearing Research Center, which is a tertial referral cen-
ter. Patients stem predominantly from the Pacific
Northwest of the United States. Thus, the documented
sample in the database cannot be considered represen-
tative of the world-wide patient population. Third, the
database does not include any validated measurements
for tinnitus severity, which have been published in the
meantime, e.g., the tinnitus handicap inventory (THI)
[22]. The THI is a widely used questionnaire validated
to assess tinnitus-related, self-reported handicaps with
high test-retest reliability [23] and has been cross-vali-
dated with other questionnaires like the tinnitus ques-
tionnaire (TQ) [24]. In contrast, when the Oregon
database was developed, only relatively rough measure-
ments of tinnitus severity were available. Fourth, the
last update of the database was in 1994. Thus, advances
in tinnitus research in the last decade with a stronger
focus on finding a cure for tinnitus result in additional
requirements for a modern database, which are only
insufficiently met by the existing Oregon Tinnitus Data
Archive. A new international database, including
patients from many centers in many countries, contain-
ing cross-sectional as well as longitudinal data from
intervention studies would largely facilitate future tinni-
tus research. An essential requirement for the
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be a standardized method of data collection and docu-
mentation, as well as standardized treatment interven-
tion. Up to now, there has been great variability in each
of the centers in the assessment of tinnitus patients. For
the assessment of tinnitus severity, many different tinni-
tus questionnaires are in use and psycho-acoustical
measurements are performed with various techniques
and methods jeopardizing the comparability and pooled
analyses of data from different centers. Since there is a
great need for the further development of new treat-
ment strategies, improving already available treatment
options and allowing individualised treatment
approaches based on reliable predictors, the establish-
ment of an international tinnitus database has been
initiated in the framework of the Tinnitus Research
Initiative (TRI). The primary aims of this database are:
￿ Subtyping of different forms of tinnitus, based on
their specific symptoms and/or their response to
treatment modalities (e.g. by cluster analysis [25])
￿ Identifying predictors for treatment response to
specific treatments
￿ Assessment of treatment outcome for specific
treatments using a modular approach
￿ Identification of candidate clinical characteristics
for delineating neurobiologically distinct forms of
tinnitus
￿ Explanation of discrepant results of different stu-
dies (e.g. by the possibility to identify differences
between the study populations)
￿ Collection of epidemiological data
￿ Cross-validation of different assessment instru-
ments in different languages
￿ Development of an individualized treatment algo-
rithm for every single patient based on the individual
diagnostic profile
￿ Delineation of subgroups with similar characteris-
tics and generating data about discriminative power
of diagnostic procedures
Materials and methods
Standardized data collection
In order to assure comparability of the data collected in
different centers, a common standard must be defined
which all participating centers have to follow. The stan-
dard for the TRI database is based on a consensus for
patient assessment and outcome measurement found by
tinnitus experts from many countries during an interna-
tional tinnitus conference in Regensburg in 2006 [26].
The participants at this conference agreed that for the
sake of inter-study comparability, a minimum of stan-
dardized assessments during diagnostic and therapeutic
evaluation of tinnitus is needed. Methods for tinnitus
patient assessment and treatment outcome measure-
ment in the database were chosen according to this con-
sensus. These core assessments consist of a detailed
tinnitus and medical history, otological examination,
psycho-acoustic measures of tinnitus and a variety of
validated questionnaires assessing tinnitus severity and
quality of life and became part of standardized case
report forms (CRF). The CRF is now available in a num-
ber of languages such as English, Flemish, French, Ger-
man, Italian, Portuguese, Spanish. In most cases
validated translations of the questionnaires were avail-
able and included in the CRF. If necessary, translations
were provided. Following the lead of accepted transla-
tion procedures [27,28] translators had to be experts in
the medical field of tinnitus, native speakers of the tar-
get language (e.g. Italian) and fluent in the source lan-
guage (i.e. English). These experts provided a forward
translation that was checked by a second person with
the same level of expertise. In case of occasional dis-
agreements, these were resolved by consensus (reconci-
liation process). The TRI database allows for such an
analysis of the psychometric properties of these newly
translated questionnaires.
Data from all forms of treatment interventions (e.g.,
pharmacological, psychotherapeutic, auditory or brain
stimulation interventions, etc.) will be entered into the
database. Treatment forms included so far in the data-
base encompass pharmaceutical interventions (63% of
all patients), brain stimulation techniques (i.e., tran-
scranial magnetic or electrical stimulation; 23% of all
patients) and cognitive behavioral therapeutic
approaches (about 12%). In the future, further treat-
ments may be added to the database. The only precon-
ditions are that treatment interventions have to be
clearly defined and performed in a standardized way.
According to various durations of the different treat-
ment interventions, the CRF was organized flexibly in
terms of both the number of visits and the intervals
between visits. Also the use of additional assessment
methods is supported by the database. However, the
core assessments are identical for all visits and all
interventions to allow cross-comparison. Table 1 gives
an example of a standardized CRF in English and how
it is used for a pharmacological trial of 12 weeks’ dura-
tion. The design of the CRF allows the documentation
of both cross-sectional and longitudinal data. Up to
now, 13 centers from 8 countries (Argentina, Brazil,
B e l g i u m ,F r a n c e ,G e r m a n y ,I t a l y ,S p a i n ,a n dN e wZ e a l -
and) have participated in the database project. CRFs
are currently available in English, Flemish, French,
German, Italian, Portuguese and Spanish. Translations
into further languages are being prepared. Finally, the
database is open to anyone who is interested in partici-
pating in the project (either by collecting data or
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dataset). Scientific agreements define the rights and
duties of each participating center. As a general rule,
every participating center has full access to its own
dataset. In addition, each center may have access to
the whole dataset under predefined conditions.
Research questions and access to the whole dataset
will be discussed within the TRI database scientific
c o m m i t t e ea n dh a st ob ea p p r o v e db yi t .F u r t h e ri n f o r -
mation on how to participate may be found on http://
database.tinnitusresearch.org or by sending an email to
database@tinnitusresearch.org.
Database construction and technical details
A novel approach to entering data for anonymous
patients has been created with strict observation of the
guidelines of Good Clinical Practice (GCP) and Federal
Drug Administration (FDA) regulations. This approach
defines each patient with a unique hash code made up
of a 40 cipher string. Since this string is not really legi-
ble in routine use for data entry, a substitute rule has
been defined to identify the patient more easily: a com-
bination of the patient number (6 ciphers) and the cen-
ter identification number (ID) (3 ciphers), linked by a
hyphen. Thus, in all cases the patient relative to the
database was anonymous, and the only people able to
recognize the patients behind the numbers were the
data entry staff members.
The environment surrounding this approach had
been made of a v5.x MySQL database and a PHP v4.x
and - after migration onto a more modern hosting ser-
ver - v5.x based application using some JavaScript func-
tionality (scarcely). For all database entries, modification,
and updating modes, PHP-based transactions have been
newly designed so as to enable both a complete usage
and error tracking system. Thus, revisions and other
changes were easy to follow and made up one part of
the users’ administration in order to modify the users’
activity (e. g. active, inactive, banned).
So as to minimize the efforts to manually enter all
CRFs, a system was designed using the German applica-
tion FormPro® to automatically scan the CRFs through a
high-volume scanner and import the recognized data
(after some corrections, if necessary) into the database.
In order to optimize and simplify data evaluation,
some of the most relevant calculations had been put
into the system first hand. The rest of the data struc-
tures were adapted to fit the mathematical needs of data
analysis.
In order to not be jeopardized by any kind of data loss
or unwanted data change, the system was finalized by a
separately developed backup system, that both incre-
mentally and completely did its job every night and put
the one-day evaluation backup file (packed and
encrypted) on a separate, specially secured FTP (SFTP)
server for downloading by the data evaluation staff.
The final enrichment of the system was done by the
development of a criteria-based validation system: Only
validated data was incorporated into the evaluation
backup file.
Table 1 Overview of the standardized content of a CRF used for pharmacological studies according to the consensus.
Measurements at each visit are graded according to essential to collect (A) or highly recommended (B).
Screening Baseline Week 2 Week 4 Week 8 Week 12 = End Week 16
Follow up
TSCHQ A
Otological Examination A
Medical history A
Audiometry AA B
Loudness match BB
Pitch match BB
Maskability BB
Residual Inhibition BB
THI A A AAAA A
TBF 12 B B BBBB B
Tinnitus Numeric Rating Scales A A AAAA A
BDI B B BBBB B
WHOQOL B B BBBB B
CGI (change) AAAA A
Concomittant medication A A AAAA A
Adverse Events AAAA A
Comorbidity A A AAAA A
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(VPN) had been recommended, a https://approach using
encrypted user logins and passwords was considered
safe. For security reasons, however, the hardening of the
underlying Linux operating system (openSuSE 10.3, later
11.1) was undertaken so as to prevent any kind of exter-
nal hacking or cracking trials. Furthermore, the system’s
logging function was set from debug (9) to paranoid
mode (10) automatically sending the log files to the sys-
tem administrator for both automatic and manual
tracking.
Data handling/quality
High emphasis has been placed on the standardization of
data collection and on assuring the quality of data hand-
ling. After completing a manual CRF data entry, each
center sends the original CRF to the central database
management at the University of Regensburg, where the
digital data entry is conducted. A copy of each CRF
remains in the individual study center. The Center for
Clinical Studies at the University Hospital in Regensburg
developed a data validation strategy and generated a
detailed data handling plan, which defines the action to
be taken in case of missing values, implausible or illegible
data, incomplete data or self-evident corrections accord-
ing to GCP guidelines. The data handling plan is the
foundation for data entry and contains several
approaches to ensure the validity of the data entered.
In addition, automatic computer-based checks during
data entry (i.e. defined value ranges, field type controls)
and regular manual checks of missing and implausible
values in the database minimize errors and upgrade the
data quality. Based on subject identification numbers,
each missing and implausible value can be located and a
query to the relevant study center is generated (query-
management).
Statistical analysis approaches
The primary goal of the database is the definition of
subgroups of tinnitus patients, who respond to a specific
treatment according to their tinnitus-specific character-
istics and concomitant medical conditions. Analyses
start with descriptive statistics using counts, proportions
(percentages), means and standard deviations, medians
and ranges. The focus will be on a backward-oriented
analysis strategy aiming to characterize patients
responding to any intervention. Responders will be
determined via changes in their tinnitus scores from
baseline to end of treatment, mostly after 8 or 12 weeks.
The criteria of minimally important clinical changes will
be established by cross-validation of the different assess-
ment instruments.
Responders will be compared to non-responders in
order to detect differences in demographic or clinical
variables. These analyses will be performed for respon-
ders versus non-responders across therapies as well as
for each single intervention separately. Significant fac-
tors indicating treatment response can then be tested in
the future in specifically designed studies. Due to the
exploratory nature of the project and the large amount
of potential important variables, the a priori specifica-
tion of a detailed statistical analysis plan is not feasible.
The statistical analysis plan will be developed as the
data base grows and results from initial analyses become
available. Ideally, results will be the basis for a decision
support tool using a set of pre-defined clinical and
demographic criteria that will help to tailor the proper
therapy for a given patient.
Discussion
The TRI database is unique in that it is the first data-
base containing standardized collected data from
patients undergoing different types of treatment inter-
ventions. Study centers from many different countries
contribute to the database. Data entered in the database
ranges from highly selected patient populations partici-
pating in controlled trials to unselected patients popula-
tions receiving standard treatments under real world
conditions. Finally, participation in the database project
is open to anyone who is willing to follow the guidelines
of data collection (i.e., using the standardized CRF).
Thus, this database enables the comparability of study
results from different clinical trials, from different cen-
ters as well as from patient populations with differing
ethnic backgrounds for the first time. The prerequisite
of such an international research project is a standar-
dized method of data collection. This standard reper-
toire of tinnitus assessment methods is based on a
consensus conference [26], and has been agreed upon
by all participating centers. Still these assessment tools
always represent a trade-off between comparability of
measurements from different centers and the most sen-
sitive measurements, which may not be available in all
centers and which depend on the intervention being
studied. Nevertheless, the search for predictors for dif-
ferent treatment responses is very much dependent on
the availability of large patient samples, which can only
be achieved in a reasonable time by pooling data from
different centers. Also the generalization of results
requires representative samples but also reliable and not
too complicated assessment procedures. Therefore, such
a compromise is necessary. Furthermore, the present set
of measurements implemented in the database repre-
sents a core set that can be used in all centers, but the
database has been constructed in a most flexible modu-
lar structure, so that additional instruments such as
results from functional imaging may be included at any
time in the future. On the other hand, if it turns out
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scientific reasons, these may be removed from the data-
base, if this is suggested by the TRI database scientific
committee.
Another major problem of tinnitus research is that
tinnitus is a subjective experience (like pain), which is
not accessible by the use of objective measurement
methods. It can only be quantified by using self-rating
questionnaires. This new database contains the most
widely used tinnitus questionnaires and therefore offers
the possibility to perform advanced analyses on the psy-
chometric properties (reliability, validity, sensitivity) of
these measures. One comparison for such evaluation
attempts may be the Clinical Global Impression Scale
(CGI; [29]), which is also used in this database and
represents a validated research tool for assessing efficacy
of treatment studies. Also, new questionnaires, which
have been specifically developed to assess change in tin-
nitus severity, may be incorporated into the database as
soon as they are available and can be cross-validated
with other questionnaires in a large patient sample.
Taken together, the TRI database represents a new,
unique research tool and can potentially facilitate the
clinical characterisation of tinnitus subtypes, the detec-
tion of predictors of individual responses to treatment
and may help individualise and improve treatment
approaches in the future.
Abbreviations
TSCHQ: Tinnitus Sample Case History Questionnaire; THI: Tinnitus Handicap
Inventory; TBF 12: Tinnitus Impairment Questionnaire; BDI: Beck Depression
Inventory; CGI: Clinical Global Impression Scale; WHOQOL: World Health
Organization - Quality of Life (Questionnaire)
Acknowledgements
This research project has been funded by a grant from the Tinnitus Research
Initiative (TRI).
Author details
1Department of Psychiatry, Psychosomatics and Psychotherapy, University of
Regensburg, Universitaetsstraße 84, 93053 Regensburg, Germany.
2Center for
Clinical Studies, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11,
93053 Regensburg, Germany.
3ManaThea GmbH, Josef-Engert-Straße 11,
93053 Regensburg, Germany.
Authors’ contributions
All authors contributed to the writing of the manuscript. ML, BL, GH
developed, designed and coordinated the international research network of
tinnitus experts, which provide clinical data sets for the database. MM
programmed the software, data handling and entry is managed by YE, SS,
JR. Statistical analyses are performed by MK and FZ. All authors have read
and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests. The ManaThea
GmbH is a private company specialized on the development of medical
software solutions and provides the technical support within this project
(development of the software, maintenance and service of the server
hosting the database, etc.). The ManaThea GmbH has no competing
interests.
Received: 19 April 2010 Accepted: 3 August 2010
Published: 3 August 2010
References
1. Axelsson A, Ringdahl A: Tinnitus–a study of its prevalence and
characteristics. Br J Audiol 1989, 23:53-62.
2. Hoffman HJ, Reed GW: Epidemiology of Tinnitus. Tinnitus: Theory and
Management Hamilton, USA: BC DeckerSnow JB 2004, 16-41.
3. Langguth B, Salvi R, Elgoyhen AB: Emerging pharmacotherapy of tinnitus.
Expert Opin Emerg Drugs 2009, 14:687-702.
4. Noble W: Treatments for tinnitus. Trends Amplif 2008, 12:236-241.
5. Dobie RA: A review of randomized clinical trials in tinnitus. Laryngoscope
1999, 109:1202-1211.
6. Rossi S, De CA, Ulivelli M, Bartalini S, Falzarano V, Filippone G, Passero S:
Effects of repetitive transcranial magnetic stimulation on chronic
tinnitus: a randomised, crossover, double blind, placebo controlled
study. J Neurol Neurosurg Psychiatry 2007, 78:857-863.
7. Plewnia C, Reimold M, Najib A, Brehm B, Reischl G, Plontke SK, Gerloff C:
Dose-dependent attenuation of auditory phantom perception (tinnitus)
by PET-guided repetitive transcranial magnetic stimulation. Hum Brain
Mapp 2007, 28:238-246.
8. Marcondes RA, Sanchez TG, Kii MA, Ono CR, Buchpiguel CA, Langguth B,
Marcolin MA: Repetitive transcranial magnetic stimulation improve
tinnitus in normal hearing patients: a double-blind controlled, clinical
and neuroimaging outcome study. Eur J Neurol 2009, 17(1):38-44.
9. Khedr EM, Rothwell JC, Ahmed MA, El-Atar A: Effect of daily repetitive
transcranial magnetic stimulation for treatment of tinnitus: comparison
of different stimulus frequencies. J Neurol Neurosurg Psychiatry 2008,
79:212-215.
10. Khedr EM, Rothwell JC, El-Atar A: One-year follow up of patients with
chronic tinnitus treated with left temporoparietal rTMS. Eur J Neurol 2009,
16:404-408.
11. Kleinjung T, Eichhammer P, Langguth B, Jacob P, Marienhagen J, Hajak G,
Wolf SR, Strutz J: Long-term effects of repetitive transcranial magnetic
stimulation (rTMS) in patients with chronic tinnitus. Otolaryngol Head
Neck Surg 2005, 132:566-569.
12. Martinez DP, Waddell A, Perera R, Theodoulou M: Cognitive behavioural
therapy for tinnitus. Cochrane Database Syst Rev 2007, CD005233.
13. Davis PB, Paki B, Hanley PJ: Neuromonics Tinnitus Treatment: third clinical
trial. Ear Hear 2007, 28:242-259.
14. Henry JA, Schechter MA, Zaugg TL, Griest S, Jastreboff PJ, Vernon JA,
Kaelin C, Meikle MB, Lyons KS, Stewart BJ: Outcomes of clinical trial:
tinnitus masking versus tinnitus retraining therapy. J Am Acad Audiol
2006, 17:104-132.
15. Moller AR: A double-blind placebo-controlled trial of baclofen in the
treatment of tinnitus. Am J Otol 1997, 18:268-269.
16. Donaldson I: Tegretol: a double blind trial in tinnitus. J Laryngol Otol 1981,
95:947-951.
17. Hulshof JH, Vermeij P: The value of carbamazepine in the treatment of
tinnitus. ORL J Otorhinolaryngol Relat Spec 1985, 47:262-266.
18. Mardini MK: Ear-clicking “tinnitus” responding to carbamazepine. N Engl J
Med 1987, 317:1542.
19. Levine RA: Typewriter tinnitus: a carbamazepine-responsive syndrome
related to auditory nerve vascular compression. ORL J Otorhinolaryngol
Relat Spec 2006, 68:43-46.
20. Meikle MB: Electronic access to tinnitus data: the Oregon Tinnitus Data
Archive. Otolaryngol Head Neck Surg 1997, 117:698-700.
21. Folmer RL, Griest SE: Chronic tinnitus resulting from head or neck
injuries. Laryngoscope 2003, 113:821-827.
22. Newman CW, Jacobson GP, Spitzer JB: Development of the Tinnitus
Handicap Inventory. Arch Otolaryngol Head Neck Surg 1996, 122:143-148.
23. Newman CW, Sandridge SA: Tinnitus questionnaires. Tinnitus - Theory and
Management Hamilton, London: BC Decker Inc.Snow JB 2004, 237-254.
24. Baguley DM, Humphriss RL, Hodgson CA: Convergent validity of the
tinnitus handicap inventory and the tinnitus questionnaire. J Laryngol
Otol 2000, 114:840-843.
25. Tyler R, Coelho C, Tao P, Ji H, Noble W, Gehringer A, Gogel S: Identifying
tinnitus subgroups with cluster analysis. Am J Audiol 2008, 17:S176-S184.
26. Langguth B, Goodey R, Azevedo A, Bjorne A, Cacace A, Crocetti A, Del BL,
De RD, Diges I, Elbert T, et al: Consensus for tinnitus patient assessment
Landgrebe et al. BMC Medical Informatics and Decision Making 2010, 10:42
http://www.biomedcentral.com/1472-6947/10/42
Page 6 of 7and treatment outcome measurement: Tinnitus Research Initiative
meeting, Regensburg, July 2006. Prog Brain Res 2007, 166:525-36, 525-536.
27. Dewolf L, Koller M, Velikova G, Johnson C, Scott N, Bottomley A, On Behalf
of the EORTC Quality of Life Group: Translation Procedure Manual.
Brussels: EORTC 2009.
28. Koller M, Aaronson NK, Blazeby J, Bottomley A, Dewolf L, Fayers P,
Johnson C, Ramage J, Scott N, West K: Translation procedures for
standardised quality of life questionnaires: The European Organisation
for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer
2007, 43:1810-1820.
29. Guy W: ECDEU Assessment Manual for Psychopharmacology Rockville: U.S.
Department of Health, Education, and Welfare 1976.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6947/10/42/prepub
doi:10.1186/1472-6947-10-42
Cite this article as: Landgrebe et al.: The Tinnitus Research Initiative
(TRI) database: A new approach for delineation of tinnitus subtypes and
generation of predictors for treatment outcome. BMC Medical Informatics
and Decision Making 2010 10:42.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Landgrebe et al. BMC Medical Informatics and Decision Making 2010, 10:42
http://www.biomedcentral.com/1472-6947/10/42
Page 7 of 7